• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在死亡时特发性肺纤维化的存在存在种族和民族差异。

Ethnic and racial differences in the presence of idiopathic pulmonary fibrosis at death.

机构信息

Autoimmune Lung Center and Interstitial Lung Disease Program, National Jewish Health, Denver, CO 80206, USA.

出版信息

Respir Med. 2012 Apr;106(4):588-93. doi: 10.1016/j.rmed.2012.01.002. Epub 2012 Jan 31.

DOI:10.1016/j.rmed.2012.01.002
PMID:22296740
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3294009/
Abstract

BACKGROUND

In studies of idiopathic pulmonary fibrosis (IPF), whites makeup the vast majority of subjects. Whether ethnic/racial differences in idiopathic pulmonary fibrosis occur in the general population is unknown.

METHODS

To compare the presence of IPF between ethnic/racial groups of U.S. decedents from 1989 to 2007 by using the National Center for Health Statistics database.

RESULTS

There were 251,058 U.S. decedents with IPF; 87.2% were non-Hispanic whites (White), 5.1% were non-Hispanic African American (black), 5.4% were Hispanic, and 2.2% were from other ethnic/racial groups (other). Whites coded with IPF died older than those in the other groups (77.9 years vs. 72.1 years for blacks, 75.3 years for Hispanics, and 75.6 years for others; p < 0.0001 for all pairwise comparisons). When controlling for age and for sex, compared with whites, both Hispanics and Others were more likely to be coded with IPF (OR = 1.47, 95% CI 1.44-1.49, p < 0.0001 and OR = 1.29, 95% CI 1.26-1.36, p < 0.0001 respectively), while blacks were significantly less likely to be coded with IPF (OR = 0.48, 95% CI 0.47-0.49, p < 0.0001). Among decedents with IPF, Hispanics were more likely, and blacks were less likely, than whites to die from IPF (OR = 1.24, 95% CI 1.20-1.29, p < 0.0001 and OR = 0.91, 95% CI 0.87-0.94, p < 0.0001).

CONCLUSION

From 1989 to 2007, black decedents were less-and Hispanics were more-likely than whites to die of/with IPF. Research is needed to determine if genetic differences between ethnic/racial groups explain these findings.

摘要

背景

在特发性肺纤维化(IPF)的研究中,白人占绝大多数研究对象。在普通人群中是否存在特发性肺纤维化的种族/民族差异尚不清楚。

方法

利用国家卫生统计中心数据库,比较 1989 年至 2007 年美国死者中不同种族/民族群体中特发性肺纤维化的存在情况。

结果

共有 251058 名美国死者患有特发性肺纤维化;87.2%是非西班牙裔白人(白人),5.1%是非西班牙裔非裔美国人(黑人),5.4%是西班牙裔,2.2%是其他种族/民族群体(其他)。白人编码的特发性肺纤维化患者比其他组的患者年龄更大(黑人的死亡率为 77.9 岁,西班牙裔为 75.3 岁,其他人的死亡率为 75.6 岁;所有两两比较均<0.0001)。在控制年龄和性别后,与白人相比,西班牙裔和其他人更有可能被编码为特发性肺纤维化(OR=1.47,95%CI1.44-1.49,p<0.0001 和 OR=1.29,95%CI1.26-1.36,p<0.0001),而黑人则不太可能被编码为特发性肺纤维化(OR=0.48,95%CI0.47-0.49,p<0.0001)。在患有特发性肺纤维化的死者中,西班牙裔比白人更有可能死于特发性肺纤维化(OR=1.24,95%CI1.20-1.29,p<0.0001),而黑人则比白人更不可能死于特发性肺纤维化(OR=0.91,95%CI0.87-0.94,p<0.0001)。

结论

从 1989 年到 2007 年,黑人死者死于/患有特发性肺纤维化的比例低于白人,而西班牙裔死于/患有特发性肺纤维化的比例高于白人。需要研究是否种族/民族群体之间的遗传差异解释了这些发现。

相似文献

1
Ethnic and racial differences in the presence of idiopathic pulmonary fibrosis at death.在死亡时特发性肺纤维化的存在存在种族和民族差异。
Respir Med. 2012 Apr;106(4):588-93. doi: 10.1016/j.rmed.2012.01.002. Epub 2012 Jan 31.
2
Racial and ethnic disparities in antifibrotic therapy in idiopathic pulmonary fibrosis.特发性肺纤维化抗纤维化治疗中的种族和民族差异。
Respirology. 2023 Nov;28(11):1036-1042. doi: 10.1111/resp.14563. Epub 2023 Aug 3.
3
State-specific prevalence of selected health behaviors, by race and ethnicity--Behavioral Risk Factor Surveillance System, 1997.按种族和族裔划分的特定州选定健康行为的患病率——行为风险因素监测系统,1997年
MMWR CDC Surveill Summ. 2000 Mar 24;49(2):1-60.
4
US birth weight/gestational age-specific neonatal mortality: 1995-1997 rates for whites, hispanics, and blacks.美国按出生体重/胎龄划分的新生儿死亡率:1995 - 1997年白人、西班牙裔和黑人的死亡率
Pediatrics. 2003 Jan;111(1):e61-6. doi: 10.1542/peds.111.1.e61.
5
Racial and ethnic patterns in the utilization of prehospital emergency transport services in the United States.美国院前急救运输服务利用中的种族和族裔模式。
Prehosp Disaster Med. 1999 Oct-Dec;14(4):232-5.
6
Representation of African-Americans, Hispanics, and whites in National Cancer Institute cancer treatment trials.非裔美国人、西班牙裔和白人在国立癌症研究所癌症治疗试验中的代表性。
J Natl Cancer Inst. 1996 Jun 19;88(12):812-6. doi: 10.1093/jnci/88.12.812.
7
Changes in COVID-19-Associated Deaths During a Year Among Blacks and Hispanics Compared to Whites in the State of Connecticut.康涅狄格州黑人和西班牙裔与白人 COVID-19 相关死亡人数在一年内的变化比较。
J Racial Ethn Health Disparities. 2022 Oct;9(5):2049-2055. doi: 10.1007/s40615-021-01143-z. Epub 2021 Sep 28.
8
Use of complementary and alternative medical therapies among racial and ethnic minority adults: results from the 2002 National Health Interview Survey.2002年美国国家健康访谈调查中种族和少数族裔成年人使用补充和替代医学疗法的情况。
J Natl Med Assoc. 2005 Apr;97(4):535-45.
9
Racial and ethnic disparities in cardiovascular risk factors among stroke survivors: United States 1999 to 2001.1999年至2001年美国中风幸存者心血管危险因素的种族和民族差异
Stroke. 2004 Jul;35(7):1557-61. doi: 10.1161/01.STR.0000130427.84114.50. Epub 2004 Jun 10.
10
Risk of colorectal adenomas and advanced neoplasia in Hispanic, black and white patients undergoing screening colonoscopy.接受筛查性结肠镜检查的西班牙裔、黑人和白人患者的结直肠腺瘤和高级别瘤变风险。
Aliment Pharmacol Ther. 2012 Jun;35(12):1467-73. doi: 10.1111/j.1365-2036.2012.05119.x. Epub 2012 Apr 29.

引用本文的文献

1
Surgical lung biopsy analyses differ by race and ethnicity in interstitial lung disease.在间质性肺疾病中,手术肺活检分析因种族和民族而有所不同。
ERJ Open Res. 2025 Jul 7;11(4). doi: 10.1183/23120541.00870-2024. eCollection 2025 Jul.
2
Health disparities and associated social determinants of health in interstitial lung disease: a narrative review.间质性肺疾病中的健康差异及相关健康社会决定因素:一项叙述性综述
Eur Respir Rev. 2025 Apr 2;34(176). doi: 10.1183/16000617.0176-2024. Print 2025 Apr.
3
Lack of diversity in antifibrotic trials for pulmonary fibrosis: a systematic review.肺纤维化抗纤维化试验缺乏多样性:一项系统评价
Eur Respir Rev. 2025 Mar 5;34(175). doi: 10.1183/16000617.0201-2024. Print 2025 Jan.
4
A prospective cohort study of abemaciclib-induced interstitial lung disease in metastatic breast cancer after chemotherapy.一项关于化疗后阿贝西利诱发转移性乳腺癌患者间质性肺疾病的前瞻性队列研究。
Breast Cancer. 2025 May;32(3):607-612. doi: 10.1007/s12282-025-01680-z. Epub 2025 Feb 10.
5
Real-world incidence of and risk factors for abemaciclib-induced interstitial lung disease in Japan: a nested case-control study of abemaciclib-induced interstitial lung disease (NOSIDE).日本阿贝西利所致间质性肺疾病的真实世界发病率及危险因素:阿贝西利所致间质性肺疾病(NOSIDE)的巢式病例对照研究
Breast Cancer. 2025 Jan;32(1):177-185. doi: 10.1007/s12282-024-01648-5. Epub 2024 Nov 18.
6
A Preliminary Study on Factors That Drive Patient Variability in Human Subcutaneous Adipose Tissues.人体皮下脂肪组织中导致患者变异性的因素初探
Cells. 2024 Jul 24;13(15):1240. doi: 10.3390/cells13151240.
7
Genome and Transcriptome-Wide Association Study of Fibrotic Sarcoidosis in European Americans.欧美人群中纤维化结节病的全基因组和转录组关联研究。
Am J Respir Crit Care Med. 2024 Feb 1;209(3):334-337. doi: 10.1164/rccm.202308-1331LE.
8
Environmental Causes of Idiopathic Pulmonary Fibrosis.特发性肺纤维化的环境病因。
Int J Mol Sci. 2023 Nov 18;24(22):16481. doi: 10.3390/ijms242216481.
9
Neighborhood Health and Outcomes in Idiopathic Pulmonary Fibrosis.特发性肺纤维化的社区健康和结局。
Ann Am Thorac Soc. 2024 Mar;21(3):402-410. doi: 10.1513/AnnalsATS.202304-323OC.
10
Outcomes of Lung Transplant Candidates Aged ≥70 Years During the Lung Allocation Score Era.≥70 岁肺移植候选人在肺分配评分时代的结局。
Ann Thorac Surg. 2024 Apr;117(4):725-732. doi: 10.1016/j.athoracsur.2023.04.046. Epub 2023 Jun 3.

本文引用的文献

1
A common MUC5B promoter polymorphism and pulmonary fibrosis.一种常见的MUC5B启动子多态性与肺纤维化。
N Engl J Med. 2011 Apr 21;364(16):1503-12. doi: 10.1056/NEJMoa1013660.
2
Familial interstitial pulmonary fibrosis: a large family with atypical clinical features.家族性间质性肺纤维化:一家系的不典型临床特征
Can Respir J. 2010 Nov-Dec;17(6):269-74. doi: 10.1155/2010/591523.
3
Rheumatoid arthritis-interstitial lung disease-associated mortality.类风湿关节炎-间质性肺疾病相关死亡率。
Am J Respir Crit Care Med. 2011 Feb 1;183(3):372-8. doi: 10.1164/rccm.201004-0622OC. Epub 2010 Sep 17.
4
Aging, antagonistic pleiotropy and fibrotic disease.衰老、拮抗多效性与纤维性疾病。
Int J Biochem Cell Biol. 2010 Sep;42(9):1398-400. doi: 10.1016/j.biocel.2010.05.010. Epub 2010 Jun 4.
5
Exposures and idiopathic lung disease.暴露因素与特发性肺病
Semin Respir Crit Care Med. 2008 Dec;29(6):670-9. doi: 10.1055/s-0028-1101277. Epub 2009 Feb 16.
6
Genetic defects in surfactant protein A2 are associated with pulmonary fibrosis and lung cancer.表面活性蛋白A2的基因缺陷与肺纤维化和肺癌有关。
Am J Hum Genet. 2009 Jan;84(1):52-9. doi: 10.1016/j.ajhg.2008.11.010. Epub 2008 Dec 18.
7
Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study.社会经济地位对癌症发病率及诊断时分期的影响:来自监测、流行病学及最终结果:国家纵向死亡率研究的选定发现
Cancer Causes Control. 2009 May;20(4):417-35. doi: 10.1007/s10552-008-9256-0. Epub 2008 Nov 12.
8
A national study of chronic disease prevalence and access to care in uninsured U.S. adults.一项关于美国未参保成年人慢性病患病率及医疗服务可及性的全国性研究。
Ann Intern Med. 2008 Aug 5;149(3):170-6. doi: 10.7326/0003-4819-149-3-200808050-00006.
9
Telomere shortening in familial and sporadic pulmonary fibrosis.家族性和散发性肺纤维化中的端粒缩短
Am J Respir Crit Care Med. 2008 Oct 1;178(7):729-37. doi: 10.1164/rccm.200804-550OC. Epub 2008 Jul 17.
10
Race differences in nicotine dependence in the Collaborative Genetic study of Nicotine Dependence (COGEND).尼古丁依赖协作基因研究(COGEND)中的尼古丁依赖种族差异。
Nicotine Tob Res. 2008 Jul;10(7):1223-30. doi: 10.1080/14622200802163266.